| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.44T | 12.32T | 13.86T | 15.02T | 10.92T | 7.66T |
| Gross Profit | 962.25B | 1.10T | 1.34T | 1.21T | 1.58T | 1.08T |
| EBITDA | 566.03B | 627.48B | 735.34B | 626.29B | 1.00T | 605.99B |
| Net Income | 184.62B | 226.07B | 288.12B | 143.77B | 537.12B | 114.00B |
Balance Sheet | ||||||
| Total Assets | 9.03T | 8.79T | 10.14T | 9.95T | 9.65T | 8.06T |
| Cash, Cash Equivalents and Short-Term Investments | 775.38B | 846.56B | 775.91B | 311.52B | 547.27B | 417.72B |
| Total Debt | 2.98T | 2.96T | 3.55T | 3.94T | 3.63T | 2.97T |
| Total Liabilities | 5.47T | 5.32T | 6.43T | 6.67T | 6.41T | 5.31T |
| Stockholders Equity | 3.19T | 3.10T | 3.23T | 2.86T | 2.86T | 2.33T |
Cash Flow | ||||||
| Free Cash Flow | 492.17B | 294.01B | 681.87B | -428.98B | -46.01B | 420.04B |
| Operating Cash Flow | 724.01B | 576.84B | 1.01T | -110.25B | 209.51B | 679.09B |
| Investing Cash Flow | 179.58B | 131.54B | -238.20B | -113.55B | -310.93B | -306.79B |
| Financing Cash Flow | -651.77B | -631.19B | -333.81B | -15.70B | 187.05B | -355.08B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥127.24B | 17.49 | ― | 2.57% | 7.46% | 153.98% | |
73 Outperform | ¥22.93B | 20.21 | ― | 4.50% | 13.76% | 13.58% | |
68 Neutral | ¥1.81T | 21.95 | 2.23% | 3.07% | -7.68% | -73.03% | |
67 Neutral | ¥74.24B | 32.15 | ― | 1.37% | -5.02% | 186.97% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
63 Neutral | ¥218.65B | 12.70 | ― | 3.45% | -4.87% | 26.27% | |
56 Neutral | ¥3.63T | 11.54 | -0.15% | 2.74% | -14.13% | 33.18% |